Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing Facility
Go back to Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing Facility| ENDO INTERNAT (NASDAQ: ENDP) | Delayed: 0.29 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.29 | 52 Week High | $63.71 | |||
| Open | $0.02 | 52 Week Low | $12.56 | |||
| Day High | $0.29 | P/E | N/A | |||
| Day Low | $0.29 | EPS | $0.00 | |||
| Volume | 24,300 | |||||
